Tag: Rick Hansen Institute
Spinal Cord Injury Research Evidence (SCIRE) Community provides free information about spinal cord injury research that is written in everyday language.
SCIRE Community is a new addition to the SCIRE Project. The SCIRE Project is an international collaboration of scientists and health professionals that provides systematic reviews of spinal cord injury research for health professionals and researchers. The aim of the SCIRE Project has been to enable SCI professionals to guide their practice based on current best evidence.
An experimental treatment that sends electrical currents through the spinal cord has improved “invisible” yet debilitating side effects for a B.C. man with a spinal cord injury.
New research provides recommendations to help manage neuropathic pain
LONDON, ONTATIO – Researchers at Lawson Health Research Institute are the first in Canada to develop clinical practice guidelines for managing neuropathic pain with patients who have experienced a spinal cord injury (SCI).
Neuropathic pain is complex and chronic, and is the most common complication reported by people following SCI. The research team worked with care providers at Parkwood Institute, part of the St. Joseph’s Health Care London family, and an international panel to address the complex and unique challenges for managing pain during recovery and rehabilitation.
Minocyline shows promise for limiting the severity of spinal cord injuries at a fraction of time and cost of other new drug treatments, says Rick Hansen Institute
VANCOUVER – The Rick Hansen Institute (RHI) is pleased to announce an international clinical trial to test promising research that suggests minocycline may decrease the severity of acute spinal cord injury (SCI).
Once used by Christopher Reeve, it was developed in part with funding from the Rick Hansen Institute.
Gabriel Abotossaway doesn’t sound like he can’t breathe on his own.
On the phone from his home in Manitoulin Island, the 22-year-old sounds like most men his age. But Gabriel has required help breathing since a 2011 car accident rendered him a high-level quadriplegic. He’s unable to move his diaphragm and breathe independently.
Spinal cord injury is one of the world’s major unsolved health-care challenges, affecting not only the individuals who live with it but also their families. It requires specialized treatment and long-term care, amounting to billions of dollars annually in Canada. As Tracy’s story illustrates, once surgery and rehabilitation are complete, the challenges faced can be relentless – from painful secondary health complications to multiple barriers to reintegration.
University of Calgary researchers working on a spinal cord injury treatment are getting some help from the Man in Motion.
The Rick Hansen Institute is helping to fund work on an old drug that shows new promise treating spinal cord injuries (SCI).
Dr. John Hurlbert, along with co-investigators Dr. Steven Casha and Dr. Voon Wee Yong have found that minocycline — originally used to treat acne — helps restore movement in patients suffering from SCI.
“We looked at this drug in a mouse model and the results were fascinating,” Hurlbert said.
Harmandeep Saini needed someone to feed him, brush his teeth, give him his medication and put his bus token in the fare box after a motorcycle accident left him a quadriplegic three years ago. Today, the 25-year-old can do these things on his own thanks to a promising new therapy that has given him back some control of his hands.
Functional electrical stimulation, or FES, involves using small amounts of electricity to push muscles into action and retrain the central nervous system.